Leap therapeutics announces reverse stock split

Cambridge, mass. , june 20, 2023 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will effect a 10-for-1 reverse stock split of its issued and outstanding common stock, effective at 5pm et on june 20, 2023.
LPTX Ratings Summary
LPTX Quant Ranking